MUSTANG BIO INC

For the period ended Dec 31, 2023. Filed Mar 11, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 11, 2024

MBIO$0.45+15.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheets as of December 31, 2023 and 2022

BALANCE SHEETS

(in thousands, except for share and per share amounts)


· · December 31, · · December 31,
· 2023 · 2022
· · · ·
ASSETS · ·
Current Assets: · ·
Cash and cash equivalents	$6,234	$75,656
Other receivables - related party	-	36
Other receivables	3,879	263
Prepaid expenses and other current assets	1,233	2,897
Total current assets	11,346	78,852

Property, plant and equipment, net	3,218	8,440
Fixed assets - construction in process	29	951
Restricted cash	750	1,000
Other assets	833	261
Operating lease right-of-use asset, net	1,566	2,918
Total Assets	$17,742	$92,422

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable and accrued expenses	$14,017	$13,731
Payables and accrued expenses - related party	834	766
Operating lease liabilities - short-term	520	612
Total current liabilities	15,371	15,109

Deferred income	270	270
Note payable, long-term, net	-	27,436
Operating lease liabilities - long-term	1,978	3,334
Total Liabilities	17,619	46,149

Commitments and Contingencies (Note 7)

Stockholders’ Equity
Preferred stock ($0.0001 par value), 2,000,000 shares authorized, 250,000 shares of Class A preferred stock issued and outstanding as of December 31, 2023 and December 31, 2022, respectively	—	—
Common stock ($0.0001 par value), 200,000,000 shares authorized as of December 31, 2023 and December 31, 2022, respectively
Class A common shares, 845,385 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively	—	—
Common shares, 8,374,869 and 7,100,111 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively	1	11
Common stock issuable, 419,089 and 187,134 shares as of December 31, 2023 and December 31, 2022, respectively	591	1,109
Additional paid-in capital	380,502	374,522
Accumulated deficit	(380,971)	(329,369)
Total Stockholders’ Equity	123	46,273
Total Liabilities and Stockholders’ Equity	$17,742	$92,422

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.